Market Overview

Benzinga's Top Upgrades, Downgrades For May 21, 2019

Share:

Top Upgrades

  • BMO Capital upgraded Polaris Industries Inc. (NYSE: PII) from Market Perform to Outperform. Polaris shares rose 4.6 percent to $89.89 in pre-market trading.
  • Analysts at Bernstein upgraded Kroger Co (NYSE: KR) from Market Perform to Outperform. Kroger rose 1.5 percent to $24.42 in pre-market trading.
  • Analysts at Canaccord Genuity upgraded Just Energy Group Inc (NYSE: JE) from Hold to Speculative Buy. Just Energy shares rose 1.3 percent to $3.25 in pre-market trading.
  • Guggenheim upgraded Tripadvisor Inc (NASDAQ: TRIP) from Sell to Neutral. TripAdvisor shares rose 1.9 percent to $45.80 in pre-market trading.
  • Bank of America upgraded Deckers Outdoor Corp (NYSE: DECK) from Neutral to Buy. Deckers Outdoor shares rose 0.1 percent to close at $142.74 on Monday.
  • Zelman upgraded Stanley Black & Decker, Inc. (NYSE: SWK) from Hold to Buy. Stanley Black & Decker rose 0.2 percent to close at $135.12 on Monday.
  • Credit Suisse upgraded Apollo Global Management LLC (NYSE: APO) from Neutral to Outperform. Apollo Global shares fell 0.6 percent to close at $32.13 on Monday.
  • Analysts at UBS upgraded S&P Global Inc (NYSE: SPGI) from Neutral to Buy. S&P Global shares fell 0.5 percent to close at $211.83 on Monday.
  • Raymond James upgraded Amneal Pharmaceuticals Inc (NYSE: AMRX) from Market Perform to Strong Buy. Amneal Pharmaceuticals rose 5.1 percent to $8.68 in pre-market trading.

 

Top Downgrades

  • Desjardins downgraded Cae Inc (NYSE: CAE) from Buy to Hold. CAE shares fell 0.4 percent to $26.57 in pre-market trading.
  • RBC Capital downgraded Gran Tierra Energy Inc (NYSE: GTE) from Top Pick to Outperform. Gran Tierra Energy shares closed at $2.14 on Monday.
  • Raymond James downgraded Ocular Therapeutix Inc (NASDAQ: OCUL) from Strong Buy to Outperform. Ocular Therapeutix shares fell 15.7 percent to $2.84 in pre-market trading.
  • Credit Suisse downgraded The Carlyle Group LP (NASDAQ: CG) from Outperform to Neutral. Carlyle shares fell 0.8 percent to close at $20.76 on Monday.
  • Credit Suisse downgraded KKR & Co Inc (NYSE: KKR) from Outperform to Neutral. KKR shares fell 0.7 percent to close at $24.50 on Monday.
  • UBS downgraded Tremont Mortgage Trust (NASDAQ: TRMT) from Buy to Neutral. Tremont Mortgage Trust rose 0.4 percent to close at $5.17 on Monday.

 

Top Initiations

  • Analysts at Credit Suisse initiated coverage on Amgen, Inc. (NASDAQ: AMGN) with an Outperform rating. The price target for Amgen is set to $208. Amgen shares closed at $168.39 on Monday.
  • Consumer Edge Research initiated coverage on Uber Technologies Inc (NYSE: UBER) with an Equal-Weight rating. Uber shares closed at $41.59 on Monday.
  • Deutsche Bank initiated coverage on Target Hospitality Corp (NASDAQ: TH) with a Buy rating. The price target for Target Hospitality is set to $14. Target Hospitality shares closed at $10.83 on Monday.
  • Analysts at Credit Suisse initiated coverage on Incyte Corporation (NASDAQ: INCY) with a Neutral rating. The price target for Incyte is set to $75. Incyte shares closed at $76.83 on Monday.
  • Canaccord Genuity initiated coverage on X4 Pharmaceuticals Inc (NASDAQ: XFOR) with a Buy rating. The price target for X4 Pharmaceuticals is set to $27. X4 Pharmaceuticals closed at $16.96 on Monday.
  • H.C. Wainwright initiated coverage on Aeglea Bio Therapeutics Inc (NASDAQ: AGRX) with a Buy rating. The price target for Aeglea Bio Therapeutics is set to $20. Aeglea Bio Therapeutics shares closed at $6.50 on Monday.
  • Analysts at DA Davidson initiated coverage on Hillenbrand, Inc. (NYSE: HI) with a Neutral rating. The price target for Hillenbrand is set to $43. Hillenbrand closed at $38.96 on Monday.
  • Empire Asset Management initiated coverage on Evolus Inc (NASDAQ: EOLS) with a Sell rating. The price target for Evolus is set to $6. Evolus closed at $17.38 on Monday.
  • Credit Suisse initiated coverage on Biogen Inc (NASDAQ: BIIB) with an Underperform rating. The price target for Biogen is set to $198. Biogen shares closed at $230.76 on Monday.
  • Analysts at Credit Suisse initiated coverage on Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) with an Outperform rating. The price target for Vertex Pharmaceuticals is set to $209. Vertex Pharmaceuticals shares closed at $165.73 on Monday.
 

Related Articles (AMGN + AGRX)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

Latest Ratings

StockFirmActionPT
UBERRBC CapitalMaintains50.0
UBERMizuhoMaintains42.0
WIXJMP SecuritiesMaintains363.0
UBERBarclaysMaintains43.0
CVIJP MorganInitiates Coverage On22.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com